Beyond dose optimization, combining L-carnitine with nutrients or drugs may synergistically enhance its multi-target metabolic effects by regulating mitochondrial function, fatty acid oxidation, and insulin signaling
Retatrutide is an investigational triple incretin receptor agonist that simultaneously activates GLP-1, GIP, and glucagon receptors, producing appetite suppression, enhanced insulin secretion, and increased energy expenditure, though long-term safety and cardiovascular outcome data are not yet available
For example, FDA-approved naltrexone reduces the rewarding effects of alcohol
So Kispeptin is obviously a key player in this whole pathway of steroid hormone release, the steroid hormones being testosterone and estrogen